We are an R&D biotech that offers accelerating, high value pipeline co-creation partnerships and CRO/CDMO services – always striving for highest quality, capital efficient execution of R&D programs from disease understanding towards IND, Phase 1, and beyond.

Our expertise spans across therapeutic/disease areas and most modalities, especially small molecules and biotherapeutics. We take pride in acting as „drug hunters“ in deep collaboration with our partners to advance science.

We leverage our industrialized, AI-powered proprietary R&D platforms such as PanOmics and iPSC technologies to drive better disease understanding and human relevance. We deploy AI and continuous manufacturing technology to allow better access to high-quality biotherapeutics. Our state-of-the-art R&D value chain, combined with highly flexible partnering business models, accelerates medicines that matter at industry-leading efficiency and cost effectiveness.